Editorial: Generic antiepileptic drugs and increased health care utilization: Fact or myth?

Neurology

Volumn 74, Issue 20, 2010, Pages 1562-1563

  Besag, Frank ^a  

^a Twinwoods Health Resource Centre ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; GENERIC DRUG; PLACEBO;

BIOEQUIVALENCE; CLINICAL PRACTICE; DRUG BLOOD LEVEL; DRUG INDUSTRY; DRUG INFORMATION; DRUG USE; EDITORIAL; EPILEPSY; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; MEDICAL PRACTICE; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; REMISSION; SEIZURE; TABLET FORMULATION; HEALTH SERVICE; NOTE; UTILIZATION REVIEW;

ANTICONVULSANTS; DRUGS, GENERIC; EPILEPSY; HEALTH SERVICES; HUMANS;

EID: 77952546854     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181e1d4b4     Document Type: Editorial

References (10)

1. Bazil CW. Epilepsy: generic substitution: are antiepileptic drugs different? Nat Rev Neurol 2009;5:587-588.
2. Andermann F, Duh MS, Gosselin A, Paradis PE. Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes. Epilepsia 2007;48:464-469.
3. Heaney DC, Sander JW. Antiepileptic drugs: generic versus branded treatments. Lancet Neurol 2007;6:465-468.
4. Berg MJ. What's the problem with generic antiepileptic drugs? A call to action. Neurology 2007;68:1245-1246.
5. Besag FM. Is generic prescribing acceptable in epilepsy? Drug Saf 2000;23:173-182.
6. Perucca E, Albani F, Capovilla G, Bernardina BD, Mich-elucci R, Zaccara G. Recommendations of the Italian League against Epilepsy working group on generic products of antiepileptic drugs. Epilepsia 2006;47(suppl 20).
7. Labiner DM, Paradis PE, Manjunath R, et al. Generic anti-epileptic drugs and associated medical resource utilization in the United States. Neurology 2010;74:1566-1574.
8. Duh MS, Andermann F, Paradis PE, et al. The economic consequences of generic substitution for antiepileptic drugs in a public payer setting: the case of lamotrigine. Dis Manag 2007;10:216-225.
9. Berg MJ, Gross RA, Tomaszewski KJ, et al. Generic substitution in the treatment of epilepsy: case evidence of breakthrough seizures. Neurology 2008;71:525-530.
10. Papsdorf TB, Ablah E, Ram S, et al. Patient perception of generic antiepileptic drugs in the Midwestern United States. Epilepsy Behav 2009;14:150-153.